山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2015年
19期
1-4
,共4页
马翠花%种靖慧%廖金凤%林永敏%卫佳%郑国光
馬翠花%種靖慧%廖金鳳%林永敏%衛佳%鄭國光
마취화%충정혜%료금봉%림영민%위가%정국광
白血病%Ramos细胞%巨噬细胞集落刺激因子%膜结合型巨噬细胞集落刺激因子%剪切体%细胞增殖%细胞周期
白血病%Ramos細胞%巨噬細胞集落刺激因子%膜結閤型巨噬細胞集落刺激因子%剪切體%細胞增殖%細胞週期
백혈병%Ramos세포%거서세포집락자격인자%막결합형거서세포집락자격인자%전절체%세포증식%세포주기
leukemia%Ramos cells%macrophage colony-stimulating factor%membrane-bound macrophage colony-stimulating factor%spliceosome%cell proliferation%cell cycle
目的:探讨膜结合型巨噬细胞集落刺激因子( mM-CSF)及其剪切体( mM-CSF-Δ)对淋巴细胞白血病Ramos细胞增殖的抑制作用。方法采用Overlap PCR法构建带有mM-CSF的真核表达质粒pTARGET-mM-CSF,再进一步构建胞内区截短30个氨基酸的表达质粒pTARGET-mM-CSF-Δ,并进行PCR及DNA双向测序鉴定。将空载体pTARGET、pTARGET-mM-CSF、pTARGET-mM-CSF-Δ质粒分别转染Ramos细胞,经G418筛选稳定表达细胞株,并用RT-PCR、Western blotting进行鉴定;MTT法检测细胞增殖,流式细胞仪检测细胞周期。结果成功构建了mM-CSF和 mM-CSF-Δ的真核表达载体,获得了稳定转染细胞株 Ramos-V、Ramos-M 和 Ramos-Δ。 Ramos-M、Ramos-Δ、Ramos-V细胞增殖能力的OD值分别为0.413±0.014、0.384±0.019、0.463±0.037,Ramos-M细胞与Ramos-Δ细胞比较,Ramos-M、Ramos-Δ细胞分别与Ramos-V细胞比较,P<0.05或<0.01。 Ramos-M、Ramos-Δ、Ramos-V细胞处于G0/G1期的比例分别为41.54%±1.22%、45.60%±1.09%、39.20%±1.53%,Ramos-M细胞与Ramos-Δ细胞比较, Ramos-M、Ramos-Δ细胞分别与 Ramos-V 细胞比较, P <0.05或<0.01。结论 mM-CSF、mM-CSF-Δ均能抑制淋巴细胞白血病Ramos细胞增殖,且后者抑制作用更强。
目的:探討膜結閤型巨噬細胞集落刺激因子( mM-CSF)及其剪切體( mM-CSF-Δ)對淋巴細胞白血病Ramos細胞增殖的抑製作用。方法採用Overlap PCR法構建帶有mM-CSF的真覈錶達質粒pTARGET-mM-CSF,再進一步構建胞內區截短30箇氨基痠的錶達質粒pTARGET-mM-CSF-Δ,併進行PCR及DNA雙嚮測序鑒定。將空載體pTARGET、pTARGET-mM-CSF、pTARGET-mM-CSF-Δ質粒分彆轉染Ramos細胞,經G418篩選穩定錶達細胞株,併用RT-PCR、Western blotting進行鑒定;MTT法檢測細胞增殖,流式細胞儀檢測細胞週期。結果成功構建瞭mM-CSF和 mM-CSF-Δ的真覈錶達載體,穫得瞭穩定轉染細胞株 Ramos-V、Ramos-M 和 Ramos-Δ。 Ramos-M、Ramos-Δ、Ramos-V細胞增殖能力的OD值分彆為0.413±0.014、0.384±0.019、0.463±0.037,Ramos-M細胞與Ramos-Δ細胞比較,Ramos-M、Ramos-Δ細胞分彆與Ramos-V細胞比較,P<0.05或<0.01。 Ramos-M、Ramos-Δ、Ramos-V細胞處于G0/G1期的比例分彆為41.54%±1.22%、45.60%±1.09%、39.20%±1.53%,Ramos-M細胞與Ramos-Δ細胞比較, Ramos-M、Ramos-Δ細胞分彆與 Ramos-V 細胞比較, P <0.05或<0.01。結論 mM-CSF、mM-CSF-Δ均能抑製淋巴細胞白血病Ramos細胞增殖,且後者抑製作用更彊。
목적:탐토막결합형거서세포집락자격인자( mM-CSF)급기전절체( mM-CSF-Δ)대림파세포백혈병Ramos세포증식적억제작용。방법채용Overlap PCR법구건대유mM-CSF적진핵표체질립pTARGET-mM-CSF,재진일보구건포내구절단30개안기산적표체질립pTARGET-mM-CSF-Δ,병진행PCR급DNA쌍향측서감정。장공재체pTARGET、pTARGET-mM-CSF、pTARGET-mM-CSF-Δ질립분별전염Ramos세포,경G418사선은정표체세포주,병용RT-PCR、Western blotting진행감정;MTT법검측세포증식,류식세포의검측세포주기。결과성공구건료mM-CSF화 mM-CSF-Δ적진핵표체재체,획득료은정전염세포주 Ramos-V、Ramos-M 화 Ramos-Δ。 Ramos-M、Ramos-Δ、Ramos-V세포증식능력적OD치분별위0.413±0.014、0.384±0.019、0.463±0.037,Ramos-M세포여Ramos-Δ세포비교,Ramos-M、Ramos-Δ세포분별여Ramos-V세포비교,P<0.05혹<0.01。 Ramos-M、Ramos-Δ、Ramos-V세포처우G0/G1기적비례분별위41.54%±1.22%、45.60%±1.09%、39.20%±1.53%,Ramos-M세포여Ramos-Δ세포비교, Ramos-M、Ramos-Δ세포분별여 Ramos-V 세포비교, P <0.05혹<0.01。결론 mM-CSF、mM-CSF-Δ균능억제림파세포백혈병Ramos세포증식,차후자억제작용경강。
Objective To investigate the inhibitory effect of membrane-bound macrophage colony-stimulating factor ( mM-CSF) and its spliceosome ( mM-CSF-Δ) on proliferation of lymphocytic leukemia cell line Ramos.Methods The eukaryotic expression plasmid of pTARGET-mM-CSF with mM-CSF was constructed with Overlap PCR, and then pTAR-GET-mM-CSF-Δof 30 amino acide located in the intracellular region of brachytmema mutation was obtained; and mean-while, they were identified by PCR and DNA sequencing.The empty vector pTARGET, pTARGET-mM-CSF and pTAR-GET-mM-CSF-Δplasmid were transfected into Ramos cells, the cell line with stable expression was screened by G418 and was detected by RT-PCR and Western blotting.Proliferation and cell cycle of these stably transfected cells were detected by MTT and flow cytometry.Results The mM-CSF and mM-CSF-Δeukaryotic expression vectors were successfully construc-ted.The stable transfectants Ramos-V, Ramos-M and Ramos-Δwere obtained.The OD of proliferation ability of Ramos-M, Ramos-Δand Ramos-V were 0.413 ±0.014, 0.384 ±0.019 and 0.463 ±0.037, respectively.Significant difference was found between the cell lines of Ramos-M and Ramos-Δ, among the cell lines of Ramos-M, Ramos-Δand Ramos-V, re-spectively (P<0.05 or P <0.01).The proportion of G0/G1 phases of Ramos-M, Ramos-Δand Ramos-V cells were 41.54%±1.22%, 45.60%±1.09% and 39.20% ±1.53%, respectively.Significant difference was found between <br> Ramos-M and Ramos-Δcells, among Ramos-M, Ramos-Δand Ramos-V cells (P<0.05 or P<0.01).Conclusion mM-CSF and mM-CSF-Δmay inhibit the proliferation of lymphocytic leukemia cell line Ramos and the inhibitory effect of the latter is stronger.